• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Video

Telemedicine can help practices thrive during the COVID-19 crisis

Author(s):

Jules Lipoff, M.D., dermatologist and assistant professor of clinical dermatology, Penn Medicine, discusses telemedicine in the era of COVID-19.

In this brief interview, Jules Lipoff, M.D., dermatologist and assistant professor of clinical dermatology, Penn Medicine, highlights some of recent changes to the Centers for Medicare & Medicaid Services telehealth coverage policy. He also offers advice to colleagues implementing changes to their practice during the COVID-19 crisis, and discusses how this pandemic may give providers the chance to prove the efficacy of telemedicine for future practice. 

For more guidance, please visit American Academy of Dermatology Teledermatology Toolkit and the coronavirus resources listed on the AAD website.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

© 2025 MJH Life Sciences

All rights reserved.